论文部分内容阅读
目的探究多索茶碱联合布地奈德对支气管哮喘患者炎症因子及呼吸功能的影响。方法 74例支气管哮喘患者随机分成实验组和对照组,各37例。对照组实施多索茶碱治疗,实验组实施多索茶碱联合布地奈德疗法,对比两组疗效。结果实验组总有效率(94.59%)显著高于对照组(78.38%),且肺通气功能改变情况明显优于对照组,差异具有统计学意义(P<0.05)。结论多索茶碱联合布地奈德治疗支气管哮喘临床疗效确切,能有效改善患者呼吸功能,临床上应引起重视。
Objective To investigate the effect of doxofylline combined with budesonide on inflammatory factors and respiratory function in patients with bronchial asthma. Methods 74 patients with bronchial asthma were randomly divided into experimental group and control group, 37 cases each. The control group was treated with doxofylline, and the experimental group was treated with doxofylline and budesonide, and the curative effect was compared between the two groups. Results The total effective rate (94.59%) in the experimental group was significantly higher than that in the control group (78.38%), and the change of pulmonary ventilation function was significantly better than that of the control group. The difference was statistically significant (P <0.05). Conclusion Doxofylline combined with budesonide in the treatment of bronchial asthma clinically effective, can effectively improve the patient’s respiratory function, should pay close attention to the clinical.